Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket

Author: Lisa Levin | December 19, 2022 07:13am

Gainers

• AIM ImmunoTech Inc. (NYSE:AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in healthy subjects.
• Camber Energy, Inc. (NYSE:CEI) shares rose 73.4% to $0.1075 in pre-market trading. Camber Energy announced a one-for-fifty reverse-stock-split.
• Agrify Corporation (NASDAQ:AGFY) rose 66% to $0.4081 in pre-market trading after dipping around 70% on Friday. Agrify announced pricing of a public offering.
• OpGen, Inc. (NASDAQ:OPGN) rose 44.9% to $0.1899 in pre-market trading after dropping around 18% on Friday. OpGen recently announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
• Nogin, Inc. (NASDAQ:NOGN) rose 40% to $0.70 in pre-market trading after declining 39% on Friday. Nogin’s Co-CEO and President Jonathan Huberman recently acquired a total of 19,300 shares at an average price of $0.90.
• Axcella Health Inc. (NASDAQ:AXLA) shares rose 35.8% to $0.22 in pre-market trading. Axcella Health shares dipped 63% on Friday after SVB Leerink downgraded the stock from Outperform to Market Perform and lowered its price target from $6 to $2.
• Troika Media Group, Inc. (NASDAQ:TRKA) rose 34.3% to $0.1347 in pre-market trading after dropping around 6% on Friday.
• Cazoo Group Ltd (NYSE:CZOO) rose 30.7% to $0.17 in pre-market trading. Cazoo recently sold its Spanish subscription business, Swipcar, to Renting Finders S.L.
• Argo Blockchain plc (NASDAQ:ARBK) rose 28.8% to $0.4935 in pre-market trading after declining 21% on Friday.
• Golden Sun Education Group Limited (NASDAQ:GSUN) rose 24.1% to $1.39 in pre-market trading.
• Innate Pharma S.A. (NASDAQ:IPHA) rose 24.2% to $2.36 in pre-market trading. Sanofi and Innate Pharma expanded collaboration for natural killer cell therapeutics in oncology.
• Akili, Inc. (NASDAQ:AKLI) shares rose 22% to $1.22 in pre-market trading after dipping 35% on Friday.
• Greenidge Generation Holdings Inc. (NASDAQ:GREE) rose 16.3% to $0.2910 in pre-market trading after dropping 39% on Friday.
• ObsEva SA (NASDAQ:OBSV) rose 15.8% to $0.1599 in pre-market trading. The company reported dismissal of moratorium proceedings.
• 17 Education & Technology Group Inc. (NASDAQ:YQ) rose 15.1% to $1.91 in pre-market trading after jumping 29% on Friday. 17 Education & Technology recently posted a Q3 loss of $0.01 per share.
• Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) rose 14.6% to $1.18 in pre-market trading after dropping 36% on Friday.
• Otonomy, Inc. (NASDAQ:OTIC) rose 11.1% to $0.10 in pre-market trading after dropping over 21% on Friday.
• Gaotu Techedu Inc. (NASDAQ:GOTU) rose 10.5% to $3.45 in pre-market trading after jumping 20% on Friday. Gaotu Techedu recently reported a third-quarter FY22 sales decline of 45.6% year-on-year to RMB606.2 million ($85.21 million).
• Inovio Pharmaceuticals, Inc. (NASDAQ:INO) rose 10% to $1.98 in pre-market trading.
• New Oriental Education & Technology Group Inc. (NYSE:EDU) rose 6.8% to $36.73 in pre-market trading.
• TAL Education Group (NYSE:TAL) rose 6.2% to $7.92 in pre-market trading after jumping 14% on Friday.

Don’t forget to check out our premarket coverage here .

Losers

• Lanvin Group Holdings Limited (NYSE:LANV) fell 42% to $5.80 in pre-market trading after surging 31% on Friday.
• Cosmos Health Inc. (NASDAQ:COSM) shares fell 37.7% to $14.33 in pre-market trading. Cosmos Health recently announced a 1-for-25 reverse stock split.
• NantHealth, Inc. (NASDAQ:NH) shares fell 27.7% to $4.11 in pre-market trading. NantHealth recently announced a 1-for-15 reverse stock split.
• Minim, Inc. (NASDAQ:MINM) fell 20.5% to $0.1692 in pre-market trading after jumping 22% on Friday.
• BeyondSpring Inc. (NASDAQ:BYSI) fell 16.7% to $1.90 in pre-market trading after climbing around 49% on Friday. BeyondSpring recently presented data with plinabulin for the prevention of docetaxel-induced neutropenia in patients with non-small cell lung cancer and breast cancer at three medical conferences.
• Synaptogenix, Inc. (NASDAQ:SNPX) fell 15.8% to $1.01 in pre-market trading. Synaptogenix shares dropped 75% on Friday after the company announced results from its Phase 2 clinical trial of Bryostatin-1 for the treatment of advanced Alzheimer's disease, in which the primary endpoint was not met with statistical significance.
• Senti Biosciences, Inc. (NASDAQ:SNTI) shares fell 15% to $1.30 in pre-market trading. JP Morgan, on Friday, initiated coverage on Senti Biosciences with a Neutral rating.
• Surrozen, Inc. (NASDAQ:SRZN) fell 11.8% to $0.3914 in pre-market trading after dropping over 7% on Friday.
• MasterBrand, Inc. (NYSE:MBC) fell 11.5% to $8.22 in pre-market trading after jumping over 20% on Friday.
• BiomX Inc. (NYSE:PHGE) shares fell 9.6% to $0.1996 in pre-market trading after jumping 63% on Friday. BiomX, last month, posted a Q3 loss of $0.23 per share.
• Ardelyx, Inc (NASDAQ:ARDX) fell 8.7% to $1.79 in pre-market trading after the company issued an update regarding the appeal to the Complete Response Letter for the New Drug Application for XPHOZAH.
• Mullen Automotive, Inc. (NASDAQ:MULN) fell 8.2% to $0.2770 in pre-market trading. Mullen Automotive recently announced it received a purchase order from Randy Marion Automotive Group for 6,000 Class 1 EV cargo vans.
• IAMGOLD Corporation (NYSE:IAG) fell 7.8% to $1.76 in pre-market trading.

Posted In: AGFY AIM AKLI ARBK ARDX AXLA BYSI CEI COEP COSM CZOO EDU GOTU GREE GSUN IAG INO IPHA LANV MBC